Skip to content
  • News
  • Compare
  • Capital
variis
  • Clinics
  • Companies
  • Protocols
  • Specialists
  • Events
  • Funds
  • Press
variis

Longevity intelligence for Singapore and Australia. Sourced and evidence-graded.

Directories

  • Clinics
  • Companies
  • Protocols
  • Specialists
  • Funds
  • Events

Read

  • Archive
  • Capital
  • Compare
  • Glossary

Markets

  • Singapore
  • Australia

variis

  • About
  • Editorial standards
  • AI transparency
  • Corrections
  • Press

Legal

  • Medical disclaimer
  • Privacy policy
  • Terms of service

AI-assisted reporting, human-reviewed. Every claim sourced and graded. Not medical advice.

© 2026 variis · Singapore · Australia

Capital · AustraliaEverlab closes an AU$65M Series A16 JunCorporate · GlobalResMed acquires Noctrix Health1 JunClinic · SingaporeNOVI partners with Novo Nordisk1 JunTrial milestone · SingaporePROMETHEUS advances to the XPRIZE Healthspan finals15 AprClinic · SingaporeSPARKD relocates to Four Seasons1 AprRegulatory · GlobalFDA approves oral orforglipron (Foundayo)1 AprClinic · SingaporeRaffles launches R17 longevity clinic1 FebClinic · SingaporeThe Longevity GP launches1 FebCapital · AustraliaEverlab closes an AU$65M Series A16 JunCorporate · GlobalResMed acquires Noctrix Health1 JunClinic · SingaporeNOVI partners with Novo Nordisk1 JunTrial milestone · SingaporePROMETHEUS advances to the XPRIZE Healthspan finals15 AprClinic · SingaporeSPARKD relocates to Four Seasons1 AprRegulatory · GlobalFDA approves oral orforglipron (Foundayo)1 AprClinic · SingaporeRaffles launches R17 longevity clinic1 FebClinic · SingaporeThe Longevity GP launches1 Feb
Singapore · ClinicalSingapore launches SPICE program to screen and prevent decline in older adults

Singapore · Clinical

Singapore launches SPICE program to screen and prevent decline in older adults

A new clinical trial will test a community-based pathway to detect early loss of intrinsic capacity in adults aged 60 and above, supporting Singapore's Decade of Healthy Ageing Action Plan.

Clinical2 min read13 Sept

Today

Where to start today.

See all events →
Fund watchBrandon Capital

Fund watch

Brandon Capital

Venture capital · >A$1B across first five funds; BB6 A$439M

ATA Medical (Healthscreening.sg) Lounge Area

Clinic of the day

ATA Medical (Healthscreening.sg)

Singapore · Singapore

Be the first to save this

Company watchResMed

Company watch

ResMed

NYSE · NYSE:RMD / ASX:RMD (CDIs)

Protocol primerStructured resistance training and strength/functional prescription

Protocol primer

Structured resistance training and strength/functional prescription

Clinical

5 sources

Dr Steven Lu is the Co-Founder and Chief Medical Officer of Everlab, leading Australia's approach to AI-driven preventative health and early disease detection.

Person spotlight

Dr Steven Lu

CMO, Everlab

Linked to 1 organisation

What to watch

No confirmed events in the near term. The events directory tracks every dated move.

More coverage

The rest of today’s briefing.

Full archive →
Category
Market
CategoryAll
MarketGlobal
Regulatory · Global

Regulatory · Global

FDA approves oral semaglutide (Wegovy)

6 Dec
Capital · Global

Capital · Global

Insilico Medicine lists on the Hong Kong Stock Exchange

30 Dec
Singapore and Australia · Capital

Singapore and Australia · Capital

Two rounds, one IPO: how Singapore and Australia are funding longevity in 2025 to 2026

29 Jun
Everlab Founding Team

Capital · Australia

Everlab closes an AU$65M Series A

16 Jun
Trial milestone · Singapore

Trial milestone · Singapore

PROMETHEUS advances to the XPRIZE Healthspan finals

15 Apr
Opening of NUS Clinical Trial Centre

Research · Singapore

NUS Clinical Trial Centre opens

1 Oct
PROMETHEUS semi-finalist in XPRIZE Healthspan featuring Prof Andrea Maier

Research · Singapore

PROMETHEUS semi-finalist in XPRIZE Healthspan

1 May
Chi Longevity Clinic and Four Seasons Hotel Executive Team

Clinic · Singapore

Chi Longevity opens at Four Seasons

1 Mar
Clinic · Singapore

Clinic · Singapore

NOVI partners with Novo Nordisk

1 Jun
Corporate · Global

Corporate · Global

ResMed acquires Noctrix Health

1 Jun
Prof. Andrea B. Maier in a research laboratory at NUS, Co-Founder of the NUS Academy for Healthy Longevity, advancing Singapore's healthy longevity research.

Singapore · Industry

Singapore pushes clinical longevity care into the mainstream

1 Jul
Morrow's founder Allen Law, argue that longevity care can move beyond elite clinics through lifestyle medicine and AI-powered approaches.

Singapore · Industry

Can longevity be designed for everyone, not just the wealthy?

1 Jul

Coverage

Science and lifestyle

Global · Protocol

Global · Protocol

GLP-1s and healthspan: a 2026 reader’s primer

Coverage

Capital and public markets

Singapore and Australia · Capital

Singapore and Australia · Capital

Two rounds, one IPO: how Singapore and Australia are funding longevity in 2025 to 2026

Coverage

Industry and regulation

Lecture hall session at NUS's Intensive Course on Healthy Longevity launched alongside its new Healthy Longevity Graduate Certificate Singapore.

Singapore · Industry

NUS launches healthy longevity graduate certificate

Morrow's founder Allen Law, argue that longevity care can move beyond elite clinics through lifestyle medicine and AI-powered approaches.

Singapore · Industry

Can longevity be designed for everyone, not just the wealthy?

Prof. Andrea B. Maier in a research laboratory at NUS, Co-Founder of the NUS Academy for Healthy Longevity, advancing Singapore's healthy longevity research.

Singapore · Industry

Singapore pushes clinical longevity care into the mainstream

Coverage

Clinical and protocols

Global · Protocol

Global · Protocol

GLP-1s and healthspan: a 2026 reader’s primer

The NUS Academy for Healthy Longevity team celebrates the launch of its Clinical Trial Centre, the facility behind PROMETHEUS, a precision geromedicine study testing tailored lifestyle, supplement and drug approaches to ageing and age-related disease.

Singapore · Clinical

New trial to test precision geromedicine for healthy ageing

Markets

38 tracked
  • Nutromics
    Diagnostics

    April 2026: Nutromics was awarded about A$3m within a A$11.2m Cooperative Research Centres Projects consortium to develop a sepsis management patch, and appointed Tom Prescott as Board Chair ahead of a planned 2027 commercial launch (company media page, nutromics.com/media). Earlier, in October 2025 it presented what it described as the first real-time in vivo multiplexed data measuring vancomycin and tobramycin simultaneously on one device at IATDMCT.

  • Atisama Therapeutics (formerly RAGE Biotech / Rage Bio Pty Ltd)
    Pharma

    15 May 2026: now operating as Atisama Therapeutics, the company announced RB042 had advanced into multiple ascending dose cohorts of its Phase 1 trial after completing three of four single ascending dose cohorts, with readouts expected in H2 2026, and appointed Bernard Coulie as Chair of the Board (source: Atisama press release carried by FNArena, 16 May 2026). This followed the A$29m Series A announced 13 November 2025, led by IP Group Australia and Hostplus with Monash Ventures.

Open the capital desk →

Clinics

33 tracked
  • Bespoke LongevityGold Coast · Australia
    Premium
  • NutraNourishSingapore · Singapore
    Premium

    CAVEAT (R2): the practitioner is NOT SMC-registered and the offering is framed as "not medical services". Include with that caveat visible; do not present as clinical care.

Compare clinics →

Every claim traced to a named source and evidence-graded. See how at editorial standards, or the public corrections log.